Rabeprazole - Wikipedia, the free encyclopedia
Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co. and is marketed by Janssen-Cilag as rabeprazole ...
http://en.wikipedia.org/wiki/Rabeprazole...
|
Rabeprazole: MedlinePlus Drug Information
1 Sep 2009 ... Features information about dosage, usage, warnings, and side effects.
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a699060.htm...
|
Rabeprazole -- AHFS Consumer Medication Information -- NCBI Bookshelf
1 Sep 2009 ... Rabeprazole is used to treat conditions where the stomach produces too much acid , including ulcers, gastroesophageal reflux disease (GERD), ...
http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=meds&part...
|
Rabeprazole: Drug Information Provided by Lexi-Comp: Merck Manual ...
A number of PPIs are available and include dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole. ...
http://www.merck.com/mmpe/lexicomp/rabeprazole.html...
|
Enantioselective disposition of rabeprazole in relation to CYP2C19 ...
Rabeprazole is metabolized to some extent by CYP2C19. The purpose of this study was to elucidate the pharmacokinetics of each rabeprazole enantiomer in ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885016/...
|
ACIPHEX(rabeprazole sodium) Delayed Release Tablets
Administration of rabeprazole to patients with mild to moderate liver impairment resulted in increased exposure and decreased elimination. ...
http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cf...
|
Note: In Vitro Activities of Rabeprazole, a Novel Proton Pump ...
The MICs of rabeprazole sodium (RPZ), a newly developed benzimidazole proton pump inhibitor (PPI), against 133 clinical Helicobacter pylori strains revealed
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC89707/...
|
American Journal of Gastroenterology - Abstract of article ...
This study was carried out to assess the efficacy and rapidity of once-daily rabeprazole (10 mg or 20 mg) in relieving symptoms in endoscopically negative
...
http://www.nature.com/ajg/journal/v97/n6/abs/ajg2002355a.htm...
|
Rabeprazole in treatment of acid peptic diseases: results of three ...
Rabeprazole, a new proton pump inhibitor, was studied in patients with acid- peptic-related diseases (duodenal ulcer, gastric ulcer, GERD) in three ...
http://www.ncbi.nlm.nih.gov/pubmed/9590413...
|
Definition of rabeprazole sodium - National Cancer Institute Drug ...
The sodium salt of the prodrug rabeprazole, a substituted benzimidazole proton pump inhibitor, with potential anti-ulcer activity. ...
http://www.nci.nih.gov/drugdictionary/?CdrID=641009...
|
